Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Racial differences in treatment of early-stage prostate cancer.

Richert-Boe KE, Weinmann S, Shapiro JA, Rybicki BA, Enger SM, Van Den Eeden SK, Weiss NS.

Urology. 2008 Jun;71(6):1172-6. doi: 10.1016/j.urology.2007.10.010. Epub 2008 Feb 15.

PMID:
18279922
2.

The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.

Pan CC, Lee JS, Chan JL, Sandler HM, Underwood W, McLaughlin PW.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1292-6.

PMID:
14630264
3.

Race, prostate cancer survival, and membership in a large health maintenance organization.

Robbins AS, Whittemore AS, Van Den Eeden SK.

J Natl Cancer Inst. 1998 Jul 1;90(13):986-90.

4.

Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.

Fowler JE Jr, Bigler SA, Bowman G, Kilambi NK.

J Urol. 2000 Jan;163(1):137-42.

PMID:
10604331
6.

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

Underwood W 3rd, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP.

Cancer. 2005 Feb 1;103(3):538-45.

7.

Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men.

Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M, MacBride S, Malkowicz SB, Rebbeck TR.

Urology. 2003 May;61(5):987-92.

PMID:
12736021
8.

Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina.

Demark-Wahnefried W, Schildkraut JM, Iselin CE, Conlisk E, Kavee A, Aldrich TE, Lengerich EJ, Walther PJ, Paulson DF.

Cancer. 1998 Jul 15;83(2):320-30.

PMID:
9669815
9.

Trends and black/white differences in treatment for nonmetastatic prostate cancer.

Klabunde CN, Potosky AL, Harlan LC, Kramer BS.

Med Care. 1998 Sep;36(9):1337-48.

PMID:
9749657
10.

Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.

Hoffman RM, Harlan LC, Klabunde CN, Gilliland FD, Stephenson RA, Hunt WC, Potosky AL.

J Gen Intern Med. 2003 Oct;18(10):845-53.

11.

Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer.

Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, Grann VR, Troxel A, Neugut AI.

J Natl Cancer Inst. 2003 Oct 15;95(20):1545-8.

12.
13.

Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.

Bennett CL, Ferreira MR, Davis TC, Kaplan J, Weinberger M, Kuzel T, Seday MA, Sartor O.

J Clin Oncol. 1998 Sep;16(9):3101-4.

PMID:
9738581
14.

Racial/ethnic disparities in the treatment of localized/regional prostate cancer.

Underwood W, De Monner S, Ubel P, Fagerlin A, Sanda MG, Wei JT.

J Urol. 2004 Apr;171(4):1504-7.

PMID:
15017208
15.

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA.

J Clin Oncol. 2010 Feb 20;28(6):1069-74. doi: 10.1200/JCO.2009.26.2469. Epub 2010 Jan 25.

16.

The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.

Heath EI, Kattan MW, Powell IJ, Sakr W, Brand TC, Rybicki BA, Thompson IM, Aronson WJ, Terris MK, Kane CJ, Presti JC Jr, Amling CL, Freedland SJ.

Urology. 2008 Jan;71(1):151-5. doi: 10.1016/j.urology.2007.08.016.

PMID:
18242385
17.

Incidence, racial differences, and prognostic significance of prostate carcinomas diagnosed with obstructive symptoms.

Brawn PN, Johnson EH, Speights VO, Riggs M, Kuhl D, Abel PD, Lind M, Bell N.

Cancer. 1994 Sep 1;74(5):1607-11.

18.

Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004.

Robbins AS, Yin D, Parikh-Patel A.

Am J Epidemiol. 2007 Jul 1;166(1):71-8. Epub 2007 Apr 9.

19.

Racial differences in the cost of treating men with early-stage prostate cancer.

Brandeis J, Pashos CL, Henning JM, Litwin MS.

J Am Geriatr Soc. 2001 Mar;49(3):297-303.

PMID:
11300241
20.

Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF.

Urology. 2004 Dec;64(6):1171-6.

PMID:
15596192
Items per page

Supplemental Content

Write to the Help Desk